Completed
Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects
NCT01631864
- Conditions
- Body Weight, Cardiovascular Diseases, Concurrent Obesity, +13 more
- Locations
-
- Novartis Investigative Site Hanover, Germany
- Novartis Investigative Site Neuss, Germany
- Novartis Investigative Site Maastricht, Netherlands